Pulmonx
LUNG
LUNG
118 hedge funds and large institutions have $244M invested in Pulmonx in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
+6
Holders Change %
+5.36%
% of All Funds
1.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
36
Reduced
34
Closed
15
Calls
$4K
Puts
$1.74M
Net Calls
-$1.74M
Net Calls Change
+$301K
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$10.4M |
| 2 |
ACM
Altium Capital Management
New York
|
+$2.14M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.23M |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$934K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$673K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$4.86M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.06M |
| 3 |
JPMorgan Chase & Co
New York
|
-$1.95M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.48M |
| 5 |
Primecap Management
Pasadena,
California
|
-$1.11M |
